Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

1.

Flawed trials, flawed analysis: why CBP should avoid rating itself.

Cooperstein R, Perle SM, Gleberzon BJ, Peterson DH.

J Can Chiropr Assoc. 2006 Jun;50(2):97-102. No abstract available.

PMID:
17549172
[PubMed]
Free PMC Article
2.

Use of fallacious arguments, Ad Hominem attacks, and biased 'expert opinions' can make CBP research 'appear flawed'.

Harrison DE, Harrison DD, Oakley PA, Haas JW.

J Can Chiropr Assoc. 2006 Sep;50(3):161-71. No abstract available.

PMID:
17549153
[PubMed]
Free PMC Article
3.

Why clinical trials of vitamin E and cardiovascular diseases may be fatally flawed. Commentary on "The relationship between dose of vitamin E and suppression of oxidative stress in humans".

Blumberg JB, Frei B.

Free Radic Biol Med. 2007 Nov 15;43(10):1374-6. Epub 2007 Aug 31. No abstract available.

PMID:
17936183
[PubMed - indexed for MEDLINE]
4.

Bias resulting from the use of 'assay sensitivity' as an inclusion criterion for meta-analysis.

Gelfand LA, Strunk DR, Tu XM, Noble RE, Derubeis RJ.

Stat Med. 2006 Mar 30;25(6):943-55.

PMID:
16196080
[PubMed - indexed for MEDLINE]
5.

Arizona's cancer clinical trials law: flawed process, flawed product.

Olson-Garewal JK, Hessler K.

Hastings Cent Rep. 2001 May-Jun;31(3):22-4. No abstract available.

PMID:
11478120
[PubMed - indexed for MEDLINE]
6.

Profitable failure: antidepressant drugs and the triumph of flawed experiments.

McGoey L.

Hist Human Sci. 2010;23(1):58-78.

PMID:
20518153
[PubMed - indexed for MEDLINE]
7.
8.

The etiology of temporomandibular disorders: implications for treatment.

Greene CS.

J Orofac Pain. 2001 Spring;15(2):93-105; discussion 106-16. Review.

PMID:
11443830
[PubMed - indexed for MEDLINE]
9.

Pulmonary hypertension trials: current end points are flawed, but what are the alternatives?

Roberts K, Preston I, Hill NS.

Chest. 2006 Oct;130(4):934-6. No abstract available.

PMID:
17035418
[PubMed - indexed for MEDLINE]
10.

High-dose chemotherapy with autotransplantation in AL amyloidosis: a flawed meta-analysis.

Mehta J, Dispenzieri A, Gertz MA.

Biol Blood Marrow Transplant. 2010 Jan;16(1):138-40; author reply 140-1. doi: 10.1016/j.bbmt.2009.09.005. Epub 2009 Sep 15. No abstract available.

PMID:
19761864
[PubMed - indexed for MEDLINE]
11.

Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy.

Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG, Mountokalakis TD.

Am J Hypertens. 2002 Feb;15(2 Pt 1):101-4.

PMID:
11863243
[PubMed - indexed for MEDLINE]
12.

Bicalutamide.

[No authors listed]

Prescrire Int. 2007 Apr;16(88):67.

PMID:
17458049
[PubMed - indexed for MEDLINE]
13.

Economic benefit analysis of primary prevention with pravastatin. Assumptions are methodologically flawed.

Freemantle N, Mason J.

BMJ. 1998 Apr 18;316(7139):1241-2. No abstract available.

PMID:
9583930
[PubMed - indexed for MEDLINE]
14.

Second-generation antiepileptic medications in children: efficacy and cognitive effects.

Weinstein S.

Expert Rev Neurother. 2003 Mar;3(2):181-92. doi: 10.1586/14737175.3.2.181.

PMID:
19810835
[PubMed]
15.

Effect of subtle positioning flaws on measured bone mineral density of the hip.

McKiernan F, Washington W.

J Clin Densitom. 2005 Fall;8(3):330-4.

PMID:
16055964
[PubMed - indexed for MEDLINE]
16.

The relation between treatment benefit and underlying risk in meta-analysis.

Sharp SJ, Thompson SG, Altman DG.

BMJ. 1996 Sep 21;313(7059):735-8. Review.

PMID:
8819447
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Of pride, prejudice, and discrimination. Why generalizations can be unfair to the individual.

Varki A.

Ann Intern Med. 1992 May 1;116(9):762-4.

PMID:
1558349
[PubMed - indexed for MEDLINE]
18.

[Studies on lung targeted niosomes of carboplatin].

Zhang JQ, Lu B.

Yao Xue Xue Bao. 2001 Apr;36(4):303-6. Chinese.

PMID:
12580062
[PubMed - indexed for MEDLINE]
19.

Some main problems eroding the credibility and relevance of randomized trials.

Ioannidis JP.

Bull NYU Hosp Jt Dis. 2008;66(2):135-9.

PMID:
18537784
[PubMed - indexed for MEDLINE]
Free Article
20.

Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?

Clarke CE.

Mov Disord. 2008 Apr 30;23(6):784-9. doi: 10.1002/mds.21918.

PMID:
18175348
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk